Company Profile

Achilles Therapeutics plc (NASDAQ: ACHL)
5:30 PM UTC, 07/03/24
Last: $0.81 Change: -0.02 %Change: -2.81% Volume: 33,827
Detailed Quote
Open: $ 0.83   Volume: 33,827
High: $ 0.83   Yield(%) 0.00
Low: $ 0.80   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 34.10M
EPS ($) -1.31   Shares Out: 41.09M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -7.37
% Price Change (last 13 weeks): -29.94
% Price Change (last 26 weeks): -4.39
% Price Change (last 52 weeks): -11.31
% Price Change (year to date): -6.64
Management Effectiveness
Return on Equity (%): -41.21
Return on Assets (%): -36.63
Return on Invested Capital (%): -28.91
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): 0.00
Price & Volume
50-day Moving Average: $0.87
200-day Moving Average: $0.93
Avg. Daily Vol. (last 50 days): 115,950
Avg. Daily Vol. (last 200 days): 328,170
52-wk high: $1.76
52-wk low: $0.74
Bid: $0.80
Ask: $0.82
Company Information
Achilles Therapeutics Plc is a biopharmaceutical company engaged in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens. The company was founded by Karl Peggs, Sergio Quezada, Mark Lowdell and Charles Swanton in November 2020 and is headquartered in London, the United Kingdom.
Achilles Therapeutics plc
245 Hammersmith Road
London GL W6 8PW

Phone: 44.20.8154.4600
Fax: n/a
http://www.achillestx.com
Per Share Data
Earnings (1year) ($): n/a
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 3.47
Cash Flow ($): -1.59
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): 0.26
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 8.57
Current Ratio (x): 8.57
LT Debt/Equity (x): 0.76
Total Debt/Equity (x): 3.24



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.